INTRODUCTION
============

The yeast *Saccharomyces cerevisiae* has been developed as a host capable of cloning large DNA fragments, as both linear and circular yeast artificial chromosomes (YACs) ([@B1],[@B2]). Once cloned in yeast, YACs can be manipulated using standard yeast genetic tools. Transfer of this modified DNA back to host cells allows the functional study of genes and their regulation ([@B1; @B2; @B3]). Recent progress on the cloning of whole bacterial genomes in yeast, and subsequent transplantation of such genomes back into their original cellular environments ([@B4]), has extended this application from the gene to the genome level.

One common technique for DNA modification in yeast is gene replacement with a counter-selectable marker that can be subsequently removed. This usually involves two homologous recombination events. First, a counter-selectable marker is recombined into a target site. Second, a DNA fragment containing the desired alteration is recombined in place of the marker. The most frequently used marker in this procedure is the *URA3* gene, which restores uracil prototrophy. Counter-selection for the replacement of the *URA3* maker is performed by treatment with 5-fluoroorotic acid (5-FOA) ([@B5]). This method is of particular importance for two reasons. First, it restores uracil auxotrophy, which can then be used again for a further round of modification. Second, it creates a seamless modification. The basic *URA3* replacement method has been improved in a number of ways. One improvement, the tandem repeat pop-out method, is widely used for gene deletion and subsequent removal of a counter-selectable marker to produce a seamless genome modification ([@B6; @B7; @B8; @B9; @B10]). Another approach is to utilize the formation of a double-strand break (DSB), generated by the rare-cutting endonuclease enzyme I-SceI, near the targeted locus to stimulate the efficiency of homologous recombination repair ([@B11]). The methods described above can be adapted for deletions, point mutations or gene replacements.

We have previously demonstrated the assembly and cloning of the synthetic *Mycoplasma genitalium* genome as a circular YAC in yeast ([@B12],[@B13]). This potentially allows us to use yeast as a platform to directly engineer or redesign synthetic bacterial genomes *in vivo*. At first, we attempted to engineer the synthetic *M. genitalium* genome in yeast by the traditional two-step method of replacement and a tandem repeat pop-out method to produce a point mutation and a deletion, respectively. Unfortunately, we were not able to isolate clones with the desired modifications in the *M. genitalium* genome due to a high background of nonspecific loss of the *URA3* marker during the course of manipulations. Therefore, we designed a method to place both tandem repeat sequences and a DSB near the target site to enhance the efficiency of target-specific recombination. We have termed this the TREC (tandem repeats coupled with endonuclease cleavage) method, and find that it can be used to seamlessly engineer bacterial genomes that are cloned in yeast.

MATERIALS AND METHODS
=====================

Yeast strain and media
----------------------

*Saccharomyces cerevisiae* yeast strain VL6-48N (*MATα his3-Δ200 trp1-Δ1 ura3-Δ1 lys2 ade2-101 met14*) housing a 0.6 Mb *Mycoplasma genitalium* whole genome YAC was constructed previously ([@B12]). Yeast cells were grown in standard rich medium containing glucose (YEPD) or galactose (YEPG); or in synthetic minimal medium containing dextrose (SD) or galactose (SG) ([@B14]). SD medium supplemented with 5-fluoroorotic acid (5-FOA) was used to select for loss of the *URA3* marker ([@B5]).

Preparation of mutagenesis cassettes
------------------------------------

Primers used for construction of all mutagenesis cassettes are listed in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1). They were synthesized by Integrated DNA Technologies (Coralville, IA, USA). Primers longer than 60 bp were purified by polyacrylamide gel electrophoresis. All polymerase chain reactons (PCRs) were performed with Takara Ex *Taq* DNA polymerase (Takara Bio Inc.) using the conditions recommended by the manufacturer. The *URA3* marker (1066 bp) was amplified from the plasmid pRS306 ([@B15]); the *GAL1* promoter (450 bp) was amplified from the plasmid pYES2 (Invitrogen, Carlsbad, CA, USA); the 1184-bp fragment containing the *GAL1* promoter and the *SCEI* gene was amplified from the plasmid pGSKU ([@B11]); and the *Cre* recombinase gene (1032 bp) was amplified from the plasmid pBS185 ([@B16]). Assembly of linear DNA fragments were performed by a PCR-fusion technique ([@B17]). In each case of PCR-based fusion, complementary ends overlapped by 40 bp ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1)). To generate each final mutagenesis cassette, a fusion product was PCR-reamplified with chimeric primers, each containing 50 bp of homology to the target site ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1)). The final constructs are illustrated in [Figures 1](#F1){ref-type="fig"} A, [2](#F2){ref-type="fig"}A, [1S](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1) and [2S](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1). Figure 1.A traditional method of genetic engineering the MG259 locus of a synthetic *M. genitalium* genome maintained in yeast. (**A**) The scheme of repairing a point mutation through two homologous recombination procedures. First, a region of 146 bp with point mutation (asterisk) in the MG259 locus of *M. genitalium* genome (M. gen genome) is replaced with the *URA3* marker via 50-bp homologous sequences. Second, a 328-bp DNA fragment replaces the *URA3* marker. The loss of the *URA3* marker is selected for by 5-FOA. Two PCR diagnosis primers (red arrows), Seq-F (gttagtttaccaatccagtc) and Seq-R (aatgcttggatatcaatatc), are separated by 0.4 kb in MG259 locus, and the insertion of the 1.1-kb *URA3* marker results in the generation of a 1.3-kb PCR product when using these primers. (**B**) PCR analysis of 22 5-FOA resistant clones after the second round of homologous recombination using primers Seq-F and Seq-R. C1, DNA purified from the yeast strain containing an *M. genitalium* genome with the *URA3* marker insertion in MG259 locus and C2, DNA purified from the yeast strain containing an *M. genitalium* genome before the insertion of *URA3* marker in MG259 locus. (**C**) Analysis of *M. genitalium* genome completeness by multiplex PCR. Ten pairs of primers should produce 10 amplicons (ranging from 0.125 to 1.25 kb in 0.1-kb increments) distributed around the *M. genitalium* genome approximately every 60 kb as shown in control C1 DNA and C2 DNA. M, 100-bp DNA ladder and 1--22: DNA analyzed from 22 5-FOA resistant colonies. (**D**) Possibilities for *URA3* marker loss from an *M. genitalium* cloned in yeast. A 583 kb of the *M. genitalium* genome was cloned as yeast artificial chromosome (YAC), carrying a histidine marker (*HIS3*) and a centromere (*CEN6*), and the *URA3* marker was inserted into the MG259 locus. 5-FOA resistant strains (5-FOA^+^) could be derived either from the replacement of the *URA3* marker with the wild type DNA fragment (R1) or from recombination between two repetitive sequences (blue arrow) (R2). Size and locations of repeat sequences are schematic. Figure 2.Seamless deletion using the TREC method. (**A**) The outline of the TREC method. Through homologous recombination, a 450-bp region located at the MG259 locus is replaced with a mutagenesis cassette that consists of a knock-out CORE (an18-bp I-SceI recognition site, the SCEI gene under the control of a GAL1 promoter, and the URA3 marker) and a DNA fragment (shown in white arrow) identical to a region upstream of the target site. The replacement generates tandem repeat sequences flanking the CORE. Galactose induces the expression of I-SceI, which generates a double-strand break (DSB) at the I-SceI site near the target locus. The DSB promotes an intra-molecular homologous recombination (dash line) between the repeat sequences, leading to an excision of the CORE. (**B**) Replica-plating steps used for selection of *M. genitalium* genome modification. *URA3* positive transformants were grown on SD-HIS-URA medium, followed by replica plating to either galactose or glucose plates. After a 2-day incubation, cells were replica-plated onto SD-HIS containing 5-FOA. 5-FOA-resistant cells were re-streaked out to produce single colonies for PCR analyses. (**C**) PCR analysis using the diagnosis primers, Seq-F and M2-det1(aagtaactagcaatttgttg), for excision of the mutagenesis cassette. DNA was prepared from 24 colonies replica-plated from either galactose or glucose plate, respectively. DNA with a precise deletion would give rise to a 0.55-kb PCR product, compared to a 1-kb PCR product from un-modified DNA. (**D**) Analysis of the integrity of the *M. genitalium* genome. Ten DNA samples from galactose-induced and -uninduced 5-FOA resistant clones in (C) were further analyzed by multiplex PCR using the same primer sets described in [Figure 1](#F1){ref-type="fig"}C. M, 100-bp DNA ladder. C, DNA purified from Ura^+^ transformants before galactose induction and 5-FOA selection.

Transformation and PCR analysis
-------------------------------

Lithium acetate integrative transformation was performed according to a published method ([@B18]). Two to three micrograms of integrative construct DNA and 25 µg of carrier DNA (salmon testis DNA, Sigma) were used in routine experiments. Isolation of total DNA from yeast for PCR analysis was performed according to a published protocol ([@B8]). Correct integration of each mutagenesis cassette was verified by PCR using diagnostic primers located upstream and downstream of the target site (described in figure legends). Multiplex PCR (MPCR) was used to confirm completeness of *M. genitalium* genomes as described previously ([@B13]). The primer set (set 3) used for MPCR was designed to produce 10 amplicons (ranging from 125 to 1025 bp in 0.1-kb increments) distributed around the *M. genitalium* genome approximately every 60 kb ([@B13]).

RESULTS
=======

Nonspecific deletions in a bacterial genome cloned in yeast
-----------------------------------------------------------

We attempted to correct a point mutation in the MG259 locus of a synthetic *M. genitalium* genome maintained in yeast by the traditional method involving two homologous recombination procedures ([Figure 1](#F1){ref-type="fig"}A). After the first homologous recombination, the exact replacement of a target region with the *URA3* marker was confirmed by PCR (data not shown). After the second round of homologous recombination, however, we were not able to identify the correct replacement of the *URA3* marker with the 328-bp DNA segment by PCR screening from 97 5-FOA resistant colonies ([Figure 1](#F1){ref-type="fig"}B and [Table 1](#T1){ref-type="table"}). These results suggest that the loss of the *URA3* marker might be due to unexpected deletions. The *M. genitalium* genome propagated as a circular YAC in yeast does not have functional complementation with its host, except histidine prototrophy. Any deletions or rearrangements in the bacterial genome are likely neutral for the yeast viability. Multiplex PCR was used to evaluate the integrity of the *M. genitalium* genome in yeast. The primer set was designed to produce 10 amplicons (ranging from 125 to 1025 bp in 0.1-kb increments) distributed around the *M. genitalium* genome approximately every 60 kb. Total DNA prepared from twenty-two 5-FOA-resistant colonies did not produce all 10 amplicons ([Figure 1](#F1){ref-type="fig"}C). Two amplicons, 0.525 kb and 0.625 kb (separated from each other by ∼ 60 kb), were absent in all clones. The MG259 locus lies between these two amplicons. This result demonstrates that some spontaneous deletions or rearrangements occur in the *M. genitalium* genome propagated in yeast. The loss of the *URA3* marker could result from homologous recombination among repetitive sequences in the *M. genitalium* genome. As a result, the cells with spontaneous deletions of the *URA3* gene could survive on 5-FOA medium. In this case, the probability of nonspecific loss of the *URA3* gene was higher than that of the *URA3* gene replacement by the incoming DNA fragment ([Figure 1](#F1){ref-type="fig"}D). In agreement with this hypothesis, the frequency of nonspecific loss of the *URA3* gene placed in the MG259 locus was ∼ 0.3% (data not shown). Table 1.Efficiency of several DNA modification methods for engineering *M. genitalium* genomes in yeastMethodFraction of clones with the correct modification[^a^](#TF1){ref-type="table-fn"}Fraction of clones with a complete genome[^b^](#TF2){ref-type="table-fn"}Traditional sequence replacement0/970/22Tandem repeat pop-out0/381/9Tandem repeat endonuclease cleavage (TREC)28/2810/10Cre/*loxP* recombinase28/304/4[^1][^2]

We also tried to make a seamless deletion of a 450-bp region within the MG259 locus by the tandem repeat pop-out approach ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1)). Again, we were not able to find the correct modification by PCR screening ([Table 1](#T1){ref-type="table"}). Multiplex PCR showed that eight out of nine 5-FOA resistant clones contained incomplete genomes ([Table 1](#T1){ref-type="table"}). Therefore, we concluded that these methods were not efficient enough to engineer the *M. genitalium* genome in yeast and that the 5-FOA-resistant cells were likely derived from cells that nonspecifically lost the *URA3* marker during the course of manipulations.

Combination of TREC
-------------------

DSBs have been introduced near the targeted-locus to stimulate the efficiency of homologous recombination repair in yeast and higher eukaryotic cells ([@B11],[@B19; @B20; @B21; @B22]). Therefore, we believed that the frequency of recombination between two tandem repeats should be enhanced by a DSB near the target site. A new mutagenesis construct was designed. It contains a CORE cassette (consisting of the18-bp I-SceI recognition site, the *GAL1* promoter, a gene encoding the I-*Sce*I endonuclease and the *URA3* gene) and 378 bp of DNA homologous to the region upstream of the target site. Two terminal sequences homologous to the target site were added into the construct by PCR ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1)). Replacement of the 450-bp target region with this construct would produce two repeat sequences franking the CORE, and homologous recombination between the repeat sequences would result in a seamless deletion ([Figure 2](#F2){ref-type="fig"}A).

Following transformation of the mutagenesis construct into yeast, the expression of I-*Sce*I endonuclease was induced by galactose. After a 2-day incubation, cells were replica-plated onto SD-His+5-FOA plates. Cells with galactose induction produced significantly more colonies on SD-His+5-FOA medium than un-induced cells ([Figure 2](#F2){ref-type="fig"}B). 5-FOA-resistant cells derived from both induced and un-induced cells were re-streaked, and single colonies were then selected and analyzed. Transformants with the correct deletion were identified by PCR screening. DNA with precise removal of the CORE cassette would result in the generation of a 0.55-kb PCR product. ([Figure 2](#F2){ref-type="fig"}C left panel) suggests that all 24 galactose-induced clones contain the correct modification in the *M. genitalium* genome, while only two PCR-positive clones isolated from un-induced cells do ([Figure 2](#F2){ref-type="fig"}C, right panel). Furthermore, the integrity of the *M. genitalium* genomes was evaluated by multiplex PCR. DNA from 10 galactose-induced clones produced the complete set of 10 amplicons (left panel, [Figure 2](#F2){ref-type="fig"}D). DNA from un-induced clones did not generate the complete set of 10 amplicons ([Figure 2](#F2){ref-type="fig"}D, right panel). Hence, results from both PCR analyses demonstrate that the TREC method can perform a seamless deletion on a bacterial genome cloned in yeast with high efficiency ([Table 1](#T1){ref-type="table"}).

The Cre-*loxP* system has been demonstrated to produce marker excision in yeast with high efficiency ([@B23]). Therefore, we compared the efficiency of the TREC method with that of the *Cre-loxP* system for gene deletion in a *M. genitalium* genome cloned in yeast. The *Cre-*loxP mutagenesis construct consists of the *Cre* gene under the control of the *GAL1* promoter, the *URA3* gene, and two mutant *loxP* sites flanked by the two terminal sequences homologous to the target site ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq099/DC1)). The mutant *loxP* sites prevent a reverse recombination event ([@B24]). The same region deleted by TREC was targeted by this construct. Following transforming, Ura^+^ clones were grown on galactose medium to induce the expression of Cre recombinase. In turn, this excises most of mutagenesis cassette, including the *URA3* gene, but leaves a 34-bp mutant *loxP* element in the target site. PCR analysis showed that 93% (28/30) of the 5-FOA resistant clones contained the desired deletion. Multiplex PCR indicated that 100% (4/4) of the correct deletion clones contained the complete *M. genitalium* genome ([Table 1](#T1){ref-type="table"}). In conclusion, we find that the efficiency of the TREC method is comparable with that of the Cre-*loxP* system in engineering an *M. genitalium* genome cloned in yeast.

DISCUSSION
==========

Several existing methods that adapt the URA3/5-FOA counter-selection have been successfully demonstrated for modification of yeast chromosomes ([@B1; @B2; @B3]). However, the two methods that we have tried are not efficient enough for engineering an *M. genitalium* genome episomally maintained in yeast. The *M. genitalium* genome seems to be relatively stable in yeast even though the genome contains up to 4% of repetitive sequences ([@B25]), but spontaneous deletions or rearrangements still occurs at a low frequency ∼2% (data not shown). This would potentially generate undesired URA3-negative clones during the course of manipulations and therefore complicate 5-FOA selection for site-specific mutagenesis.

We have demonstrated that the TREC method is a very efficient tool to produce seamless modifications in the *M. genitalium* genome in yeast. It is a simple method that only needs a single transformation and is adaptable to other kinds of modifications (insertions, gene replacements or point mutations). The high frequency of homologous recombination of the TREC method is mainly attributable to the fact that every cell, in principle, is engaging in repair during the induction of the DSB and that the repair substrates (repeat sequences and DSB) are in close proximity. The performance of TREC is comparable with the *Cre/loxP* system. However, since TREC does not leave a scar, the TREC method offers a significant advantage over the *Cre/loxP* system in genomic engineering. Recently, a new method, called MIRAGE, was reported for generating a seamless modification in the *S. cerevisiae* yeast genome with high efficiency ([@B26]). This method is based on the introduction of an inverted repeat near the target site, flanked by two short tandem repeats. The unstable inverted repeat greatly promotes an excision between the two tandem repeats. However, the inverted repeat sequences may lead to imprecise deletions due to replication slippage ([@B27],[@B28]). Furthermore, the MIRAGE method requires a complicated knockout construct to be generated, which may take more than a day to prepare. In contrast, the TREC construct can be generated and transformed into yeast on the same day.

A similar strategy has been developed for making seamless modifications in *Escherichia coli* ([@B29],[@B30]). It also involves the introduction of both I-*Sce*I induced DSB and tandem repeat sequences near the target site and requires the assistance of lambda red for homologous recombination. This method makes *E. coli* a powerful host for molecular engineering. However, unlike the mega-base pair cloning capacity of yeast, cloning foreign DNA \>300 kb in *E. coli* is not very common, which limits its application.

Delivering an engineered YAC back to its original cell can determine the function and regulation of genes and gene clusters ([@B1; @B2; @B3]). Seamless modification is a favorable means of engineering a YAC, since additional sequences remaining in engineered site could potentially cause unexpected consequences. In addition, chromosomes of many higher eukaryotic cells contain a high fraction of repetitive sequences. The method described here should be beneficial for modifying their gene(s) cloned in yeast. Furthermore, we have also applied TREC method to easily generate a variety of genomic modifications, including gene insertion, deletion and mutation correction, in both the synthetic *M. genitalium* genome and a *Mycoplasma mycoides* (*M. mycoides*) genome (∼1 Mb) cloned in yeast (unpublished data). One of these engineered clones, YCpMmyc1.1-*ΔtypeIIIres*, is a seamless deletion of a Type III restriction enzyme gene. The genome purified from this clone has been transplanted into a *Mycoplasma capricolum* to produce an *M. mycoides* cell with the desired genome modification ([@B4]). Together, since the yeast *S. cerevisiae* has been successfully demonstrated as a host for the assembly of the synthetic *M. genitalium* genome, TREC becomes an important tool in yeast to engineer synthetic genomes, which could be used to produce synthetic cells.
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[^1]: ^a^Estimated by diagnostic PCR.

[^2]: ^b^Estimated by multiplex PCR assay.
